From: CDER MEDWATCH LISTSERV
Subject: FDA - MedWatch - OxyContin - Illegal Promotion By Manufacturer
May Cause Health Risks For Consumers
MedWatch - The FDA Safety Information and Adverse Event Reporting
Program
FDA informed healthcare professionals of criminal charges and civil
liabilities brought against Purdue Frederick in connection with several
illegal schemes to promote, market and sell OxyContin, a powerful
prescription pain reliever that the company produces. The manufacturer's
sales force was trained to make false claims about the product to
healthcare professionals, thereby, misbranding OxyContin by illegally
promoting the drug as being less addictive, less subject to abuse, and
less likely to cause tolerance and withdrawal than other pain
medications. These practices falsely promote the product and may cause
health risks for consumers.
Read the complete 2007 Safety summary, including a link to the FDA Press
Release regarding this issue at:
http://www.fda.gov/medwatch/safety/2007/safety07.htm#OxyContin
No comments:
Post a Comment